FDA’s Implementing Visionary: A Conversation With COO John Dyer
Executive Summary
FDA's efforts to help usher in the bioinformatics era are personified by Deputy Commissioner for Operations John Dyer
You may also be interested in...
FDA Re-Org Makes Chief Of Staff Liaison Between Centers And Commissioner
A newly created FDA Office of the Chief of Staff will serve as the major point of contact between FDA centers and offices, and the Commissioner, according to an Aug. 30 Federal Register notice
FDA Re-Org Makes Chief Of Staff Liaison Between Centers And Commissioner
A newly created FDA Office of the Chief of Staff will serve as the major point of contact between FDA centers and offices, and the Commissioner, according to an Aug. 30 Federal Register notice
FDA Reform Bill Leaves Senate With Reduced Safety Powers But Stiffer Fines
Legislation to reauthorize FDA's user fee program and expand the agency's oversight powers on drug safety has cleared the Senate with much stronger fines than originally envisioned by the sponsors, thanks to an amendment by Sen. Charles Grassley, R-Iowa